Display Settings:

Format

Send to:

Choose Destination
    Gut. 1988 May;29(5):580-7.

    Lactosylceramide in inflammatory bowel disease: a biochemical study.

    Source

    Queen Elizabeth Hospital for Children, London.

    Abstract

    A simple technique for isolating lipids from small pieces of tissue was applied to mucosal biopsies and samples of resected intestine from patients with inflammatory bowel disease. Scanning densitometry of two dimensional chromatograms showed increased concentrations of the membrane associated glycosphingolipid lactosylceramide in Crohn's disease, on comparison with ulcerative colitis (p less than 0.01), or controls (p less than 0.01). This indicates either that normal glycosphingolipid metabolism is altered, or that a novel source of lactosylceramide is present in the inflamed mucosa of patients with Crohn's disease.

    PMID:
    3396945
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1433632
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk